Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-26 @ 1:19 PM
NCT ID:
NCT00571506
Eligibility Criteria:
Inclusion Criteria:
* Men and women of all races
* Age 40-65 years
* Diagnosis of type 2 diabetes
* hemoglobin A1C ≥ 7%
* eligible whether or not currently taking antihyperglycemic medications
Exclusion Criteria:
* History of rosiglitazone or pioglitazone use in the previous 3 months
* Known diagnosis of peripheral vascular disease or cardiac failure
* Recent history (within past 6 months) of ischemic stroke, myocardial infarction, percutaneous coronary intervention, or coronary artery bypass surgery
* Active liver disease or elevated serum transaminases (ALT \>2.5x upper limit of normal)
* Current therapy with oral anticoagulants (warfarin, heparin, low molecular weight heparin), clopidogrel, or immunosuppressive agents
* Pregnancy or breastfeeding
* Any other condition, in the opinion of the investigator, that renders the subject unable to complete the study, that interferes with optimal participation in the study, or that produces significant risk to the subject
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
65 Years
Study:
NCT00571506
Study Brief:
Protocol Section:
NCT00571506